NCT07156578 A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO) Status ENROLLING_BY_INVITATION Phase PHASE2
NCT06760546 A Trial of Setmelanotide in Patients With Congenital Hypothalamic Obesity (Sub-study of NCT05774756) Status RECRUITING Phase PHASE3
NCT06299891 Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity Status RECRUITING Phase PHASE2
NCT06239116 A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment Status RECRUITING Phase PHASE1/PHASE2
NCT06217848 The Effect of GLP-1 Agonist in Patients With Hypothalamic Obesity: Prospective, Pilot Study Status RECRUITING Phase EARLY_PHASE1
NCT06046443 A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity Status COMPLETED Phase PHASE2
NCT05774756 A Trial of Setmelanotide in Acquired Hypothalamic Obesity Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT05319301 Identification and Clinical Relevance of an Oxytocin Deficient State (Melatonin Study) Status COMPLETED Phase NA
NCT05147415 Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO) Status WITHDRAWN Phase PHASE2
NCT03673813 A Personalized Program of Physical Activity and Diet for Hypothalamic Obesity Status COMPLETED Phase N/A
NCT02860923 Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy Status COMPLETED Phase PHASE3
NCT02664441 Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity Status COMPLETED Phase PHASE3
NCT01783717 Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage Status UNKNOWN Phase NA
NCT00892073 Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy Status COMPLETED Phase PHASE2
NCT00171613 A Study of Octreotide Depot vs Saline Control in Pediatric Hypothalamic Obesity Patients Status COMPLETED Phase PHASE4